AMGN vs VRTX: Which Stock is Better?

Side-by-side comparison of Amgen Inc and Vertex Pharmaceuticals Inc in 2026

Comparison Updated:

AMGN

Amgen Inc

$388.16

VRTX

Vertex Pharmaceuticals Inc

$496.83

Key Metrics Comparison

MetricAMGNVRTXWinner
Market Cap$209.24B$126.19BAMGN
P/E Ratio27.2432.47AMGN
EPS (TTM)$14.25$15.30VRTX
Revenue Growth0.1%0.1%VRTX
Gross Margin70.8%53.7%AMGN

Analyze AMGN

Full quant analysis

Analyze VRTX

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is AMGN or VRTX a better investment?

Comparing AMGN and VRTX: Amgen Inc has a market cap of $209.24B while Vertex Pharmaceuticals Inc has $126.19B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between AMGN and VRTX?

AMGN (Amgen Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: AMGN or VRTX?

Based on P/E ratios, AMGN trades at a lower multiple (27.2x vs 32.5x).

Which is growing faster: AMGN or VRTX?

VRTX has higher revenue growth at 0.1% vs 0.1% for AMGN.

Which company is more profitable: AMGN or VRTX?

Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 53.7% for VRTX.

Which is the larger company: AMGN or VRTX?

Amgen Inc (AMGN) is larger with a market cap of $209.24B compared to $126.19B for VRTX.

Should I buy AMGN or VRTX in 2026?

Both AMGN and VRTX have investment merit. AMGN trades at $388.16 while VRTX trades at $496.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between AMGN and VRTX stock?

Key differences: Market Cap ($209.24B vs $126.19B), P/E Ratio (27.2x vs 32.5x), Revenue Growth (0.1% vs 0.1%), Gross Margin (70.8% vs 53.7%).

Popular Stock Comparisons